Amy Vandenberg serves as Executive at OBALON THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Amy Vandenberg has executed 7 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 6, 2019 involved purchasing 2,500 shares valued at $10.0K.
Amy Vandenberg currently holds 11,764 shares of OBALON THERAPEUTICS INC (OBLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy Vandenberg has been a net buyer of OBLN stock. They have purchased $10.0K and sold $0 worth of shares.
Amy Vandenberg's most recent insider trade was on Aug 6, 2019, when they purchased 2,500 shares at $4.00 per share.
Get notified when new Form 4 filings are submitted
| $1.82 |
| Discretionary |
| May 15, 2018 | OBLN | $0 | Award | 15,000 | $N/A | Discretionary |
| Jan 29, 2018 | OBLN | $3.5K | Option Exercise | 4,022 | $0.87 | Discretionary |
| Jan 29, 2018 | OBLN | $2.0K | Option Exercise | 1,541 | $1.31 | Discretionary |
| Jan 29, 2018 | OBLN | $946 | Option Exercise | 1,087 | $0.87 | Discretionary |
| Jan 2, 2018 | OBLN | $0 | Award | 60,000 | $N/A | Discretionary |